Site Search
Search Results
Community Letter in Support of the DIVERSE Trials Act (H.R. 5030/S. 2706)
ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the ... allow sponsors to provide patients with technology necessary to facilitate remote participation in clinical trials; and require the Department of Health and Human Services (HHS) to create guidance on the use of decentralized trials to increase trial diversity. Community Letter in Support of the DIVERSE Trials Act (H.R. 5030/S. 2706) ...
Priority Issue
State
Policy Issue
- (-) Remove Research, Funding and Drug Development filter Research, Funding and Drug Development